Galvanize Therapeutics, Inc. — Form D
Galvanize Therapeutics, Inc. of Redwood City, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-09-11. The offering totals $141.1M, of which $96.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-09-11
- Form: D
- Accession: 0001659073-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $141.1M
- Amount sold: $96.1M
- Remaining: $44.9M
- Investors: 28
- Date of first sale: 2025-07-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-557260
Issuer
- Name: Galvanize Therapeutics, Inc.
- CIK: 0001659073
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 3200 Bridge Parkway, Redwood City, CA, 94065
- Phone: 650-268-4252
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Doug Godshall | Director | Bloomington, MN |
| Seth Harrison | Director | Redwood City, CA |
| David Lewis | Director | BOSTON, MA |
| Antoine Papiernik | Director | Redwood City, CA |
| Zack Scott | Director | Emeryville, CA |
| Steve Anheier | Executive Officer | Redwood City, CA |
| Doug Godshall | Executive Officer | Bloomington, MN |
| Jonathan Waldstreicher | Executive Officer | Redwood City, CA |
| Jonathan Waldstreicher | Director | Redwood City, CA |
| David McIntyre | Director | Maple Grove, MN |
Other filings by this issuer (4)
More